This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback

Anti-Obesity Effect of Pediococcus Pentosaceus LP28

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Fumiko Higashikawa, Hiroshima University
ClinicalTrials.gov Identifier:
NCT01685944
First received: September 12, 2012
Last updated: February 25, 2016
Last verified: February 2016
  Purpose
This study is designed to evaluate efficacy of Pediococcus pentosaceus LP28 in reducing body fat and body weight in subjects with BMI 25-30 kg/m2.

Condition Intervention
Obesity Dietary Supplement: Live Pediococcus pentosaceus LP28 Dietary Supplement: Heat-killed Pediococcus pentosaceus LP28 Dietary Supplement: Placebo

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double Blind (Participant, Investigator, Outcomes Assessor)
Primary Purpose: Prevention
Official Title: A Randomized, Double-blind, Placebo Controlled Study to Evaluate the Effect of Pediococcus Pentosaceus LP28 on Obesity

Further study details as provided by Fumiko Higashikawa, Hiroshima University:

Primary Outcome Measures:
  • Body fat [ Time Frame: Every 4 weeks (Overall 12 weeks) ]
  • BMI [ Time Frame: Every day (Overall 14 weeks) ]
    Body weight will be measured every morning.


Secondary Outcome Measures:
  • Abdominal circumference [ Time Frame: Every 4 weeks (Overall 12 weeks) ]
  • Serum triglyceride [ Time Frame: Every 4 weeks (Overall 12 weeks) ]
  • Total cholesterol [ Time Frame: Every 4 weeks (Overall 12 weeks) ]
  • LDL cholesterol [ Time Frame: Every 4 weeks (Overall 12 weeks) ]
  • HDL cholesterol [ Time Frame: Every 4 weeks (Overall 12 weeks) ]
  • Fasting blood glucose [ Time Frame: Every 4 weeks (Overall 12 weeks) ]
  • Fasting insulin [ Time Frame: Weeks 0 and 12 ]
  • HOMA-R [ Time Frame: Weeks 0 and 12 ]
  • Adiponectin [ Time Frame: Weeks 0 and 12 ]
  • Leptin [ Time Frame: Weeks 0 and 12 ]
  • Resistin [ Time Frame: Weeks 0 and 12 ]

Enrollment: 62
Study Start Date: August 2012
Study Completion Date: April 2013
Primary Completion Date: April 2013 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Placebo Comparator: Placebo Dietary Supplement: Placebo
Experimental: Live Pediococcus pentosaceus LP28 Dietary Supplement: Live Pediococcus pentosaceus LP28
Experimental: Heat-killed Pediococcus pentosaceus LP28 Dietary Supplement: Heat-killed Pediococcus pentosaceus LP28

  Eligibility

Ages Eligible for Study:   20 Years to 70 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • BMI 25-30 kg/m2

Exclusion Criteria:

  • Taking medicines or functional food that may affect body weight or body fat
  • Pregnant or nursing a child
  • Participation in any clinical trial within 90 days of the commencement of the trial
  • Renal or hepatic dysfunction
  • Heart disease
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01685944

Locations
Japan
Hiroshima University
Hiroshima, Japan, 734-8551
Sponsors and Collaborators
Hiroshima University
Investigators
Principal Investigator: Fumiko Higashikawa, PhD Hiroshima University
  More Information

Responsible Party: Fumiko Higashikawa, Associate Professor, Hiroshima University
ClinicalTrials.gov Identifier: NCT01685944     History of Changes
Other Study ID Numbers: eki-619
Study First Received: September 12, 2012
Last Updated: February 25, 2016

Additional relevant MeSH terms:
Obesity
Overnutrition
Nutrition Disorders
Overweight
Body Weight
Signs and Symptoms

ClinicalTrials.gov processed this record on June 28, 2017